Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7319

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement including aromatic ring, methoxy group, cyclohexane ring, and functional groups clearly labeled as part of the venlafaxine hydrochloride molecule.*

FDA Label Image

Image-02 (Image 02)

A data table showing pharmacokinetic fold changes and 90% confidence intervals of venlafaxine and its O-desmethylvenlafaxine (ODV) metabolite Cmax and AUC across special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60, and gender differences, compared to a reference value.*

FDA Label Image

Image-03 (Image 03)

A chart depicting fold changes and 90% confidence intervals for the pharmacokinetics (Cmax and AUC) of venlafaxine and its metabolite ODV when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value.*

FDA Label Image

Image-04 (Image 04)

A forest plot chart titled 'Fold Change and 90% CI' showing the fold change in pharmacokinetic parameters (Cmax and AUC) for various analytes after interaction with different drugs. The chart lists interacting drugs and their analytes on the left, with corresponding Cmax and AUC values plotted as points with confidence intervals relative to the reference value at 1 on the horizontal axis.*

FDA Label Image

Label Image (Lbl500907319)

Venlafaxine Hydrochloride extended-release capsules, 75 mg, in a 90-capsule package labeled by A-S Medication Solutions. The label includes storage instructions to keep the product between 68 to 77 degrees Fahrenheit and mentions the product NDC 50090-7319. Dosage instructions are referred to as being on an insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.